Literature DB >> 3383042

Treatment of postural hypotension with aerosol ergotamine.

K Siminoski1, C Lukinuk, P W Armstrong.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383042      PMCID: PMC1267988     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Aerosol ergotamine tartrate for migraine and Horton's syndrome.

Authors:  J R GRAHAM; B P MALVEA; H F GRAMM
Journal:  N Engl J Med       Date:  1960-10-20       Impact factor: 91.245

2.  Orthostatic hypotension: clinical spectrum and approach to treatment.

Authors:  M V Tantengco; J Onrot; D Robertson; R M Robertson; R T Light
Journal:  Compr Ther       Date:  1986-06

3.  Treatment of orthostatic hypotension with dihydroergotamine.

Authors:  G Jennings; M Esler; R Holmes
Journal:  Br Med J       Date:  1979-08-04

Review 4.  Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Authors:  V L Perrin
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

5.  Treatment of chronic orthostatic hypotension with ergotamine.

Authors:  A V Chobanian; C P Tifft; D P Faxon; M A Creager; H Sackel
Journal:  Circulation       Date:  1983-03       Impact factor: 29.690

Review 6.  Management of chronic orthostatic hypotension.

Authors:  J Onrot; M R Goldberg; A S Hollister; I Biaggioni; R M Robertson; D Robertson
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

7.  Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy.

Authors:  F M Fouad; R C Tarazi; E L Bravo
Journal:  Clin Pharmacol Ther       Date:  1981-12       Impact factor: 6.875

  7 in total
  1 in total

Review 1.  Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.

Authors:  Sabine Eschlböck; Gregor Wenning; Alessandra Fanciulli
Journal:  J Neural Transm (Vienna)       Date:  2017-10-22       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.